Additionally, HF–HC–HSD feeding resulted in CD133 (Figure 6a) increase at 49-weeks, no significant change in Nanog (Figure 6b) and a significant increase in vimentin (Figure 6c) from 27-weeks. The gene discussed is NANOG; the disease is hydrops fetalis.